Title : Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancer.

Pub. Date : 2017 Dec

PMID : 29285378

1 Functional Relationships(s)
Compound Name
Protein Name
1 Thus, neoadjuvant therapy with FEC followed by nab-PTX for operable HER2-negative breast cancer was found to be a safe and effective option. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens